Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital
Suga, Takeshi, Oiwa, Hiroshi, Ishida, Michihiro, Iwamoto, Yasuo
Published in Clinical rheumatology (01.09.2022)
Published in Clinical rheumatology (01.09.2022)
Get full text
Journal Article